Literature DB >> 8168136

Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells.

C A Turner1, D H Mack, M M Davis.   

Abstract

We describe a novel gene, Blimp-1 (for B lymphocyte-induced maturation protein), transcripts of which are rapidly induced during the differentiation of B lymphocytes into immunoglobulin secretory cells and whose expression is characteristic of late B and plasma cell lines. The 856 amino acid open reading frame contains five Krüppel-type zinc finger motifs and proline-rich and acidic regions similar to those of known transcription factors. Serological studies show an approximately 100 kd protein that localizes to the nucleus. Stable or transient transfection of Blimp-1 into B cell lymphoma lines leads to the expression of many of the phenotypic changes associated with B cell differentiation into an early plasma cell stage, including induction of J chain message and immunoglobulin secretion, up-regulation of Syndecan-1, and increased cell size and granularity. Thus, Blimp-1 appears to be a pleiotropic regulatory factor capable of at least partially driving the terminal differentiation of B cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168136     DOI: 10.1016/0092-8674(94)90321-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  256 in total

1.  Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor.

Authors:  A Chittka; M V Chao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.

Authors:  Loren D Erickson; Brigit G Durell; Laura A Vogel; Brian P O'Connor; Marilia Cascalho; Teruhito Yasui; Hitoshi Kikutani; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells.

Authors:  F Medina; C Segundo; A Campos-Caro; I Salcedo; A García-Poley; J A Brieva
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

4.  Effect of cell density on in vitro mouse immunoglobulin E production.

Authors:  Dania Rabah; Daniel H Conrad
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

5.  Alpha6-integrin is expressed on germinal centre B cells and modifies growth of a B-cell line.

Authors:  Helen E Ambrose; Simon D Wagner
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

6.  Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis.

Authors:  María Rodríguez Martínez; Alberto Corradin; Ulf Klein; Mariano Javier Álvarez; Gianna M Toffolo; Barbara di Camillo; Andrea Califano; Gustavo A Stolovitzky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

7.  Mechanistic insights into the impairment of memory B cells and antibody production in the elderly.

Authors:  Judith H Aberle; Karin Stiasny; Michael Kundi; Franz X Heinz
Journal:  Age (Dordr)       Date:  2012-01-27

8.  PRDM1 is a tumor suppressor gene in natural killer cell malignancies.

Authors:  Can Küçük; Javeed Iqbal; Xiaozhou Hu; Phillip Gaulard; Laurence De Leval; Gopesh Srivastava; Wing Yan Au; Timothy W McKeithan; Wing C Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

9.  Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1.

Authors:  Christopher A Lord; David Savitsky; Raquel Sitcheran; Kathryn Calame; Jo Rae Wright; Jenny Pan-Yun Ting; Kristi L Williams
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.

Authors:  Dina Schneider; Maria A Manzan; Byung Sun Yoo; Robert B Crawford; Norbert Kaminski
Journal:  Toxicol Sci       Date:  2009-02-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.